Friday 6 November 2026
Export NTRA’s income statement to Excel — free account
Natera, Inc.
NTRA Healthcare Diagnostics & Research
Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.
- Revenue
- +34.1%
- EPS
- +34.4%
- Free cash flow
- −85.8%
- Total debt
- −0.06%
Quarter to September 2026, against a year earlier
311.66
52.10
−14.32%
Follow NTRA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 6 | — |
| (14.32%) | (15.02%) | (12.54%) | (10.55%) | ||
| (10.26%) | (10.41%) | (8.71%) | (7.21%) | ||
ROIC |
(27.03%) | (26.44%) | (22.34%) | (8.35%) | |
Return on Tangible Assets |
(16.05%) | (16.60%) | (13.51%) | (11.25%) | |
Average Days of Receivables |
46.93 | 60.95 | 56.89 | 59.14 | |
Free Cash Flow per Share |
0.80 | 0.74 | 0.59 | 0.36 | |
Free Cash Flow |
109.11 | 104.51 | 84.20 | 52.47 | |
Capital Expenditures |
(106.19) | (106.51) | (144.04) | (160.32) | |
| Other line items | |||||
Cash ROIC |
3.80% | 3.55% | 2.81% | 2.69% | |
Accounts Receivable Turnover |
7.55 | 6.80 | 7.40 | 7.68 | |
Accounts Payable Turnover |
23.88 | 17.19 | 16.80 | 0.00 | |
Inventory Turnover |
14.36 | 14.43 | 13.98 | 0.00 | |
Average Days of Payables |
14.89 | 26.07 | 29.14 | 0.00 | |
Days of Inventory on Hand |
30.73 | 29.55 | 31.16 | 0.00 | |
Tax Rate |
(0.22) | (0.21) | (0.24) | (0.27) | |
Research and Development Expense of Revenue |
27.06% | 28.22% | 29.09% | 29.44% | |
Selling, General and Administrative Expense of Revenue |
51.05% | 49.52% | 46.36% | 44.01% | |
Share Based Compensation of Revenue |
15.37% | 14.86% | 14.09% | 13.64% | |
Interest Coverage |
(76.16) | (81.96) | (75.89) | — | |
Operating CF/Net income |
(1.03) | (0.93) | (1.19) | (1.29) | |
Depreciation/Fixed assets |
0.18 | 0.20 | 0.21 | 0.00 | |
Capex/Depreciation |
(2.44) | (1.95) | (2.19) | 0.00 | |
Revenue per Share |
16.87 | 17.67 | 18.89 | 20.19 | |
Operating CF per Share |
1.57 | 1.49 | 1.59 | 1.48 | |
Capex per Share |
(0.78) | (0.75) | (1.01) | (1.11) | |
Capex to Sales |
0.05 | 0.04 | 0.05 | 0.06 |
Columns are period end dates · fundamentals updated 5 Nov 2026